| ²é¿´: 683 | »Ø¸´: 2 | ||
txalexľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÁòËáÇâÂÈßÁ¸ñÀ×ÖÆ¼ÁרÀûÎÊÌâ
|
|
×î½ü¿ªÊ¼½ÓÊÖÕâ¸öÏîÄ¿£¬ÓйØ×¨ÀûÎÊÌ⻹²»ÊǺÜÈ·¶¨£ºÏÖÔÚÅ·ÃËÄDZßÓÐÒ»ÆªÖÆ¼ÁרÀû£¬¹úÄÚÒ²ÓÐһƪ¡£ÎÒ¶ÔÓÚÕâÁ½Æª×¨Àû¾ßÌå±£»¤µÄÄÚÈÝÓÐЩÄò»×¼£¬Çó¸ßÊÖ°ïæ¡£ Õ⼸ƪרÀûÔÚµÚÒ»ÌõÖ÷ȨÀûÒªÇóÖж¼ÁоÙÁË´¦·½ÖÐÓõ½µÄһЩ¸¨Áϲ¢ÇÒÈ«²¿¶ÔÆäʹÓÃÁ¿½øÐÐÁËÏÞÖÆ£¬ÎÒÏëÎÊÏÂÎÒÊDz»ÊǾͲ»¿ÉÒÔʹÓøÃרÀûÀïÁоٵĸ¨ÁÏ£¿»¹ÊÇÎÒ¿ÉÒÔʹÓõ«ÊDz»ÄÜÍêÈ«°´ÕÕרÀûÀïÃæµÄ¸¨ÁÏÖÖÀàºÍÓÃÁ¿À´Ê¹Óã¿ÓÐÒ»µã²î±ð¾Í¿ÉÒÔÁË£¿ ÒÔÏÂΪŷÃËרÀûµÄǰ¼¸Ìõ£º Summary of the Invention [0007] One general aspect, relates to a tablet of a clopidogrel salt comprising a therapeutically effective amount of a clopidogrel salt; lactose; stearic acid; and one or more of other pharmaceutically acceptable excipients; wherein clopidogrel salt is hydrobromide or hydrochloride. [0008] Another aspect, relates to a tablet of a clopidogrel salt comprising a therapeutically effective amount of a clopidogrel salt; lactose and microcrystalline cellulose; stearic acid; and one or more of other pharmaceutically acceptable excipients wherein clopidogrel salt is hydrobromide or hydrochloride. [0009] Yet another aspect, relates to a tablet of a clopidogrel salt comprising a therapeutically effective amount of a clopidogrel salt; lactose; stearic acid and hydrogenated castor oil; and one or more of other pharmaceutically acceptable excipients; wherein clopidogrel salt is hydrobromide or hydrochloride. [0010] Another aspect, relates to a tablet of a clopidogrel salt comprising a therapeutically effective amount of a clopidogrel salt; lactose and microcrystalline cellulose; stearic acid and hydrogenated castor oil; and one or more of other pharmaceutically acceptable excipients; wherein clopidogrel salt is hydrobromide or hydrochloride. [0011] Another aspect, relates to a tablet of a clopidogrel salt comprising a therapeutically effective amount of a clopidogrel salt, prepared by process comprising the steps of (a) blending the clopidogrel salt with the one or more of the diluents and other pharmaceutically acceptable excipients; (b) mixing one or more of the lubricants with the blend of step (a); and (c) compressing the final blend of step (b) into tablet; wherein the clopidogrel salt is hydrobromide or hydrochloride. [0012] A further aspect, relates to a tablet of a clopidogrel salt comprising a therapeutically effective amount of a clopidogrel salt, prepared by process comprising the steps of (a) blending the clopidogrel salt with lactose and other pharmaceutically acceptable excipients; (b) mixing stearic acid with the blend of step (a); and (c) compressing the final blend of step (b) into tablet; wherein the clopidogrel salt is hydrobromide or hydrochloride. [0013] Another aspect, relates to a tablet of a clopidogrel salt comprising a therapeutically effective amount of a clopidogrel salt, prepared by process comprising the steps of (a) blending the clopidogrel salt with lactose and microcrystalline cellulose and optionally other pharmaceutically acceptable excipients; (b) mixing stearic acid with the blend of step (a); and (c) compressing the final blend of step (b) into tablet; |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : 200610063151-ÂÈßÁ¸ñÀ×ÁòËáÑεÄ...-Éó¶¨ÊÚȨ.pdf
- ¸½¼þ 2 : 200710047897-ÂÈßÁ¸ñÀ×ÇâäåËáÑÎ...-Éó¶¨ÊÚȨ.pdf
- ¸½¼þ 3 : 201010252488-Ò»ÖÖÂÈßÁ¸ñÀ×»òÆä...-Éó¶¨ÊÚȨ.pdf
- ¸½¼þ 4 : EP1970054A2.pdf
- ¸½¼þ 5 : 200810305453-ÂÈßÁ¸ñÀ׵ĹÌÌåÖÆ...-Éó¶¨ÊÚȨ.pdf
2012-06-15 10:02:44, 395.85 K
2012-06-15 10:02:46, 527.83 K
2012-06-15 10:02:49, 242.19 K
2012-06-15 10:02:52, 83.64 K
2012-06-15 10:03:14, 1.68 M
» ²ÂÄãϲ»¶
µ÷¼Á
ÒѾÓÐ3È˻ظ´
08¹¤Ñ§µ÷¼Á
ÒѾÓÐ15È˻ظ´
ÕÐ08¿¼Êýѧ
ÒѾÓÐ16È˻ظ´
340Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
²ÄÁÏר˶ÕÒµ÷¼Á
ÒѾÓÐ4È˻ظ´
0854µç×ÓÐÅÏ¢Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
0805 316Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0854 ¿¼Ñе÷¼Á ÕÐÉúÁË£¡AI ·½Ïò
ÒѾÓÐ17È˻ظ´
¡¾¿¼Ñе÷¼Á¡¿»¯Ñ§×¨Òµ 281·Ö£¬Ò»Ö¾Ô¸ËÄ´¨´óѧ£¬³ÏÐÄÇóµ÷¼Á
ÒѾÓÐ15È˻ظ´
×ÊÔ´Óë»·¾³ µ÷¼ÁÉêÇë(333·Ö)
ÒѾÓÐ7È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ͼֽÖеÄÎÊÌâ ¼±Ðè
ÒѾÓÐ9È˻ظ´
¡¾×ª¡¿½â¶ÁÖÆÒ©Ç¿Õß·¢Õ¹Àú³Ì£¬ÍÚ¾òÇ¿Õß×ö´ó×öÇ¿¾Ñé
ÒѾÓÐ12È˻ظ´
ÁòËáÇâÂÈßÁ¸ñÀ×ÔÚË®ÖеÄÈܽâ¶ÈÎÊÌâ
ÒѾÓÐ13È˻ظ´
ÂÈßÁ¸ñÀ׺Ͱ¢Íз¥Ëû͡ΪʲôÔÁÏÒ©ÅúµÄ¶à£¬ÖƼÁÅúµÄÉÙ£¿
ÒѾÓÐ27È˻ظ´
ÇóÖúÁòËáÇâÂÈßÁ¸ñÀ×µÄPKaÖµ
ÒѾÓÐ3È˻ظ´
¡¾ÌÖÂÛ¡¿×¨ÀûÎÊÌâ
ÒѾÓÐ6È˻ظ´
¡¾ÇóÖú¡¿¹ØÓÚÂÈßÁ¸ñÀ×µÄÎÊÌâ
ÒѾÓÐ10È˻ظ´
¡¾·ÖÏí¡¿ÍøÂç×ÊÔ´ÔÚÐÂÒ©Ñз¢ÖеÄÓ¦ÓÃ
ÒѾÓÐ13È˻ظ´
¡¾Çë½Ì¡¿ÂÈßÁ¸ñÀ×ÁòËáÑκÍÂÈßÁ¸ñÀ×ÁòËáÇâÑÎÇø±ð
ÒѾÓÐ9È˻ظ´
txalex
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 51 (³õÖÐÉú)
- ½ð±Ò: 2184.8
- ºì»¨: 25
- Ìû×Ó: 421
- ÔÚÏß: 82.1Сʱ
- ³æºÅ: 1155581
- ×¢²á: 2010-11-25
- ÐÔ±ð: GG
- רҵ: Ò©¼Áѧ
2Â¥2012-06-15 10:04:02
plc88
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 14 (СѧÉú)
- ½ð±Ò: 1630.5
- É¢½ð: 9
- ºì»¨: 1
- Ìû×Ó: 701
- ÔÚÏß: 222.8Сʱ
- ³æºÅ: 1369881
- ×¢²á: 2011-08-16
- ÐÔ±ð: MM
- רҵ: Ò©¼Áѧ

3Â¥2012-06-15 15:00:19













»Ø¸´´ËÂ¥
5